Zanzalintinib (XL092) in combination with atezolizumab for previously treated metastatic colorectal cancer

by on 30 d'octubre de 2023 with No hi ha comentaris
  • Tabernero, J., Saeed, A., Parikh, A., Wang, Y., Wang, Z., Schwickart, M., . . . Hecht, J. (2023). Zanzalintinib (XL092) in combination with atezolizumab for previously treated metastatic colorectal cancer. Annals of Oncology, 34, S25-S26. https://doi.org/10.1016/j.annonc.2023.04.091

 

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *